跳至主要内容
临床试验/EUCTR2008-001684-11-GB
EUCTR2008-001684-11-GB进行中(未招募)不适用

A Pilot Study into the Effect of Topical Menthol for Patients with Neuropathic-Type Pain. - Topical menthol in neuropathic-type pain.

niversity of Edinburgh0 个研究点开始时间: 2008年4月25日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patients with neuropathic-type pain.
  • 2.Male or female aged 18 years or over at study entry.
  • 3.Patients whose usual medical team agree to their taking part in the study.
  • 4.Patients who provide written consent to participation in the study after explanation of the study protocol.
  • 5.Patients who consent to the relevant parts of their medical notes being accessed by the Research Team.
  • 6.Patients who, in the opinion of the investigator, are willing and able to attend as an outpatient and are able to complete the various assessments.
  • 7.Patients need to have the ability to complete questionnaire assessments in English language.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Patients with any contraindication to the use of topical therapy or menthol.
  • 2.Patients who are confused or suffering from significant psychiatric illness, which would hinder their completion of the study.
  • 3.Patients whose condition is unstable or rapidly deteriorating, such that they are unlikely to be able to contribute to the study.
  • 4.Patients with any other medical condition that would confound the objectives of the study.
  • 5.Patients who would be adversely affected by study participation. This would include those who find completion of the study too burdensome.
  • 6.Patients who, in the opinion of the Research Team or their usual medical team, would be unable to complete the study protocol for any other reason.
  • 7.Patients who are unable or refuse to provide written consent to inclusion in the study after explanation of the study protocol.

研究者

发起方
niversity of Edinburgh

相似试验